Exacerbation of hepatitis B infection following cessation of lamivudine therapy [1]

International Journal of STD and AIDS

Volumn 11, Issue 10, 2000, Pages 684-

  Barlow, G D ^a   France, A J ^a  

^a King's Cross Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; RITONAVIR; ZIDOVUDINE;

ADULT; CASE REPORT; COMORBIDITY; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIVER FUNCTION TEST; PRIORITY JOURNAL; VIRUS HEPATITIS; VIRUS INFECTION; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LAMIVUDINE; RECURRENCE;

EID: 0033788828     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462001914931     Document Type: Letter

References (4)

1. The need to exercise caution in the management of patients co-infected with HIV and hepatitis B
2. Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine
3. Reactivation of hepatitis B in patients with human immunodeficiency virus infection treated with combination therapy